IRAMINE 8MG 8MG CHLORPHENIRAMINE MALEATE TABLETS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

CHLORPHENIRAMINE MALEATE

Available from:

MAVLAB PTY. LTD.

INN (International Name):

chlorpheniramine maleate(8mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

CHLORPHENIRAMINE MALEATE ANTIHISTAMINE Active 8.0 mg/Tb

Units in package:

100 Tabs

Class:

VM - Veterinary Medicine

Therapeutic group:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Therapeutic area:

ANTI-HISTAMINE

Therapeutic indications:

PRURITIS | ALLERGIC SKIN DISORDER

Product summary:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [PRURITIS]; DOG: [PRURITIS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [PRURITIS]; DOG: [PRURITIS]; For the relief of pruritus associated with allergic skin disorders in dogs and cats.Contraindicated for use in animals with glaucoma, prostate disease, stomach or intestinal obstruction, urinary obstruction, certain heart or lung diseases, high blood pressure or hyperthyroidism. Contraindicated for use in pregnant or lactating animals.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                100% Label Size
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
IRAMINE
ACTIVE CONSTITUENT: Each tablet contains:
8mg CHLORPHENIRAMINE MALEATE
(equivalent to 5.6mg chlorpheniramine)
For the relief of pruritus associated with
allergic skin disorders in dogs and cats
100
TABLETS
DIRECTIONS FOR USE: CONTRAINDICATIONS: Contraindicated for use in
animals with glaucoma, prostate disease, stomach or intestinal
obstruction,
urinary obstruction, certain heart or lung diseases, high blood
pressure or
hyperthyroidism. Contraindicated for use in pregnant or lactating
animals.
DOSAGE AND ADMINISTRATION - DOGS: 2-8mg chlorpheniramine maleate or
½ tablet for dogs less than 10 kg, 1 tablet for dogs 10-25 kg and 1
tablet for
dogs greater than 25 kg. Administer every 8-12 hours (2-3 times per
day).
CATS: 1-2mg chlorpheniramine maleate (¼ tablet) every 8-12 hours.
FIRST AID: If poisoning occurs, contact a doctor or Poisons
Information
Centre. Phone Australia 13 11 26
STORAGE: Store below 30°C (Room Temperature). Replace lid tightly
after
use. DISPOSAL: Dispose of empty container by wrapping
in paper and placing in garbage.
APVMA APPROVAL NO. 60426/100 (0108)
DS 04/08 A
AUSTRALIAN OWNED
8MG CHLORPHENIRAMINE MALEATE TABLETS
29-33 ROWLAND ST SLACKS CREEK QLD 4127
Expiry Date:
Batch Number:
WWW.MAVLAB.COM.AU
8
mg
Info
PEST

Verified
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                MAVLAB 
PTY 
LTD 
      Date 
of 
Issue: 
October 
2008 
    MATERIAL 
SAFETY 
DATA 
SHEET 
IRAMINE 8 MG  
 
 
 
 
 
 
 
 
Page 1 of 4 
 
MSDS version: 
0 
Date of Revision: 
October 2008 
Update of section: 
All sections 
 
SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER 
Product (material) name:   
Iramine 8mg Chlorpheniramine Maleate Tablets 
Other names: 
 
 
8 mg Chlorpheniramine Tablets; C3100 
Recommended use: 
 
For the relief of pruritus associated with allergic
skin disorders in dogs and cats 
Supplier Details:   
 
Mavlab Pty Ltd ACN 068 507 148 
    31 
– 
33 
Rowland 
Street 
 
 
 
 
SLACKS CREEK    QLD    4127 
Contact 
Person: 
  Dr 
Paul 
Ross 
Emergency Telephone: 
 
(07) 3808 1399 
Facsimile: 
  (07) 
3808 
4328 
SECTION 2 HAZARDS IDENTIFICATION 
This product not dangerous goods under the Australian Code for
the Transport of Dangerous Goods by Road and 
Rail (ADG Code) but is classified as hazardous according to the
classification criteria of NOHSC:1008(2004), 
Approved Criteria For Classifying Hazardous Substances and
the National Code of Practice for the Preparation of 
Material Safety Data Sheets 2
nd
 Edition [NOHSC:2011(2003)] 
 
Although this material could be classified as dangerous goods
on the basis of its toxicity, the pack sizes in which it is 
supplied are below the minimum size for such a classification under
the ADG Code. 
Health Effects  
Risk Phrase: 
 
R25 - Toxic if swallowed. 
Safety Phrases:   
S36/37/39-45 - Wear suitable protective clothing, gloves, and
eye/face protection.  In case 
 
 
 
of accident or if you feel unwell, seek medical advice immediately
(show the label where  
   possible). 
This material is presented in tablet form and it is therefore not
expected to pose inhalational or dermal health 
hazards.  However, if tablet integrity is compromised and dust is
gener
                                
                                Read the complete document